Tofajak 5mg 60 Tablets

Babies: Safe if prescribed. Lactating mothers: It is not recommended to use in breastfeeding as tofajak capsule may be secreted in human milk and may cause harm to the baby. Pregnancy: It is not recommended to use in pregnant women as it may cause harm to the fetus.
Please consult your doctor. Driving: Tofocitinib citrate capsule does not affect the ability to drive. Alcohol: Alcohol usually does not interact with medication. If you have experienced any side effects, please consult your doctor. Liver: Tofaticinib citrate capsules should be used in caution with patients suffering from liver disease.
You may require a dose adjustment and regular monitoring of liver function. Seek doctor advice before using this medication.
Kidney: Tofajak capsules should be used in caution with patients suffering from kidney disease. You may require a dose adjustment and regular monitoring of kidney function.
Seek your doctor's advice before using this medication. .

Nasopharingitis Upper respiratory tract infection Diarrhoea Headache Hypertension Rash Nausea Anemia .

Tofajak capsule is an antirheumatic, gastrointestinal and musculoskeletal agent. It works by inhibiting the action of the enzyme janus kinase.
In rheumatoid arthritis, this reduces inflammation and joint damage. .

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• It may take 3 to 6 months to notice the full effect of this medication. Please continue to take it as directed. • Regular blood tests may be ordered by your doctor to monitor your liver function, kidney function, blood counts, or cholesterol levels. • Tofajak capsules can make it more difficult for people to fight infections.
Inform your doctor if you have infection symptoms such as fever, chills, cough, or muscle aches. • Before beginning treatment with this medication, your doctor may order a tb (tuberculosis) skin test and a chest x-ray. • Notify your doctor if you are pregnant, planning to become pregnant, or are breastfeeding..

Serious • Tofajak + Abatacept: Concurrent use may lead to increased risk of infection • Tofajak + Abciximab: Concurrent use may lead to an increased risk of immunosuppression • Tofajak + Adalimumab: Concurrent use may lead to an increased risk of immunosuppression • Tofajak + Adenovirus vaccine: Concurrent use may lead to an increased risk of immunosuppression • Tofajak + Alefacept: Concurrent use may lead to an increased risk of immunosuppression • Tofajak + Alemtuzumab: Concurrent use may lead to an increased risk of immunosuppression Monitor closely • Tofajak + Boceprevir: Concurrent use may lead to increased tofacitinib toxicity • Tofajak + Clarithromycin: Concurrent use may lead to increased tofacitinib toxicity • Tofajak + Cobicistat: Concurrent use may lead to increased tofacitinib toxicity • Tofajak + Conivaptan: Concurrent use may lead to increased tofacitinib toxicity • Tofajak + Fluconazole: Concurrent use may lead to increased tofacitinib plasma concentrations.